▶ 調査レポート

ヒトプロトロンビン複合体のグローバル市場2021

• 英文タイトル:Global Human Prothrombin Complex Sales Market Report 2021

QYResearchが調査・発行した産業分析レポートです。ヒトプロトロンビン複合体のグローバル市場2021 / Global Human Prothrombin Complex Sales Market Report 2021 / QAF27722資料のイメージです。• レポートコード:QAF27722
• 出版社/出版日:QYResearch / 2021年4月1日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、133ページ
• 納品方法:Eメール(即日納品)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本市場調査資料では、世界のヒトプロトロンビン複合体市場について種類別(500 IU/Vial、600 IU/Vial、1000 IU/Vial、その他)、用途別(血友病B、ビタミンK欠乏症、その他)、地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2016年~2027年までの市場規模と予測(販売量、売上、価格)、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・ヒトプロトロンビン複合体市場の概要
・世界の主要地域別ヒトプロトロンビン複合体市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界のヒトプロトロンビン複合体市場規模2016-2021:種類別(500 IU/Vial、600 IU/Vial、1000 IU/Vial、その他)
・世界のヒトプロトロンビン複合体市場予測2012-2027:種類別(500 IU/Vial、600 IU/Vial、1000 IU/Vial、その他)
・世界のヒトプロトロンビン複合体市場規模2016-2021:用途別(血友病B、ビタミンK欠乏症、その他)
・世界のヒトプロトロンビン複合体市場予測2012-2027:用途別(血友病B、ビタミンK欠乏症、その他)
・ヒトプロトロンビン複合体のアメリカ市場規模と予測2016-2021
・ヒトプロトロンビン複合体のヨーロッパ市場規模と予測2016-2021
・ヒトプロトロンビン複合体の中国市場規模と予測2016-2021
・ヒトプロトロンビン複合体の日本市場規模と予測2016-2021
・ヒトプロトロンビン複合体の東南アジア市場規模と予測2016-2021
・ヒトプロトロンビン複合体のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Takeda、CSL、Grifols、Octapharma、Hualan Biological、Meheco Xinxing Pharma)
・ヒトプロトロンビン複合体の製造コスト分析
・販売チャネル、流通業者、顧客
・ヒトプロトロンビン複合体の市場動向・機会・課題
・調査の結論

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The global average price of Human Prothrombin Complex is in the increasing trend, from 124 USD/Unit in 2013 to 137 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Human Prothrombin Complex includes 500 IU/Vial, 600 IU/Vial, 1000 IU/Vial and others, and the proportion of 500 IU/Vial in 2017 is about 51%.
Human Prothrombin Complex is widely used in Hemophilia B, Vitamin K Deficiency and other diseases. The most proportion of Human Prothrombin Complex is Hemophilia B, and the proportion of sales is 48%.
North America is the largest consumption place, with a consumption market share nearly 46% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 33%.
Market competition is not intense. Shire, CSL, Grifols, Octapharma, Hualan Biological, Meheco Xinxing Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Market Analysis and Insights: Global Human Prothrombin Complex Market
The global Human Prothrombin Complex market was valued at US$ 1588.3 in 2020 and will reach US$ 3101.6 million by the end of 2027, growing at a CAGR of 11.8% during 2022-2027.

Global Human Prothrombin Complex Scope and Market Size
The global Human Prothrombin Complex market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Prothrombin Complex market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others

Segment by Application
Hemophilia B
Vitamin K Deficiency
Others

The Human Prothrombin Complex market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Prothrombin Complex market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Takeda
CSL
Grifols
Octapharma
Hualan Biological
Meheco Xinxing Pharma

レポート目次

1 Human Prothrombin Complex Market Overview
1.1 Human Prothrombin Complex Product Scope
1.2 Human Prothrombin Complex Segment by Type
1.2.1 Global Human Prothrombin Complex Sales by Type (2016 & 2021 & 2027)
1.2.2 500 IU/Vial
1.2.3 600 IU/Vial
1.2.4 1000 IU/Vial
1.2.5 Others
1.3 Human Prothrombin Complex Segment by Application
1.3.1 Global Human Prothrombin Complex Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hemophilia B
1.3.3 Vitamin K Deficiency
1.3.4 Others
1.4 Human Prothrombin Complex Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Prothrombin Complex Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Prothrombin Complex Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Prothrombin Complex Price Trends (2016-2027)

2 Human Prothrombin Complex Estimates and Forecasts by Region
2.1 Global Human Prothrombin Complex Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Prothrombin Complex Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Prothrombin Complex Sales Market Share by Region (2016-2021)
2.2.2 Global Human Prothrombin Complex Revenue Market Share by Region (2016-2021)
2.3 Global Human Prothrombin Complex Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Prothrombin Complex Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Prothrombin Complex Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Prothrombin Complex Estimates and Projections (2016-2027)
2.4.2 Europe Human Prothrombin Complex Estimates and Projections (2016-2027)
2.4.3 China Human Prothrombin Complex Estimates and Projections (2016-2027)
2.4.4 Japan Human Prothrombin Complex Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Prothrombin Complex Estimates and Projections (2016-2027)
2.4.6 India Human Prothrombin Complex Estimates and Projections (2016-2027)
3 Global Human Prothrombin Complex Competition Landscape by Players
3.1 Global Top Human Prothrombin Complex Players by Sales (2016-2021)
3.2 Global Top Human Prothrombin Complex Players by Revenue (2016-2021)
3.3 Global Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Prothrombin Complex as of 2020)
3.4 Global Human Prothrombin Complex Average Price by Company (2016-2021)
3.5 Manufacturers Human Prothrombin Complex Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Prothrombin Complex Market Size by Type
4.1 Global Human Prothrombin Complex Historic Market Review by Type (2016-2021)
4.1.1 Global Human Prothrombin Complex Sales Market Share by Type (2016-2021)
4.1.2 Global Human Prothrombin Complex Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Prothrombin Complex Price by Type (2016-2021)
4.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Prothrombin Complex Sales Forecast by Type (2022-2027)
4.2.2 Global Human Prothrombin Complex Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Prothrombin Complex Price Forecast by Type (2022-2027)
5 Global Human Prothrombin Complex Market Size by Application
5.1 Global Human Prothrombin Complex Historic Market Review by Application (2016-2021)
5.1.1 Global Human Prothrombin Complex Sales Market Share by Application (2016-2021)
5.1.2 Global Human Prothrombin Complex Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Prothrombin Complex Price by Application (2016-2021)
5.2 Global Human Prothrombin Complex Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Prothrombin Complex Sales Forecast by Application (2022-2027)
5.2.2 Global Human Prothrombin Complex Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Prothrombin Complex Price Forecast by Application (2022-2027)

6 North America Human Prothrombin Complex Market Facts & Figures
6.1 North America Human Prothrombin Complex Sales by Company
6.1.1 North America Human Prothrombin Complex Sales by Company (2016-2021)
6.1.2 North America Human Prothrombin Complex Revenue by Company (2016-2021)
6.2 North America Human Prothrombin Complex Sales Breakdown by Type
6.2.1 North America Human Prothrombin Complex Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Prothrombin Complex Sales Breakdown by Type (2022-2027)
6.3 North America Human Prothrombin Complex Sales Breakdown by Application
6.3.1 North America Human Prothrombin Complex Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Prothrombin Complex Sales Breakdown by Application (2022-2027)

7 Europe Human Prothrombin Complex Market Facts & Figures
7.1 Europe Human Prothrombin Complex Sales by Company
7.1.1 Europe Human Prothrombin Complex Sales by Company (2016-2021)
7.1.2 Europe Human Prothrombin Complex Revenue by Company (2016-2021)
7.2 Europe Human Prothrombin Complex Sales Breakdown by Type
7.2.1 Europe Human Prothrombin Complex Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Prothrombin Complex Sales Breakdown by Type (2022-2027)
7.3 Europe Human Prothrombin Complex Sales Breakdown by Application
7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)

8 China Human Prothrombin Complex Market Facts & Figures
8.1 China Human Prothrombin Complex Sales by Company
8.1.1 China Human Prothrombin Complex Sales by Company (2016-2021)
8.1.2 China Human Prothrombin Complex Revenue by Company (2016-2021)
8.2 China Human Prothrombin Complex Sales Breakdown by Type
8.2.1 China Human Prothrombin Complex Sales Breakdown by Type (2016-2021)
8.2.2 China Human Prothrombin Complex Sales Breakdown by Type (2022-2027)
8.3 China Human Prothrombin Complex Sales Breakdown by Application
8.3.1 China 242 Sales Breakdown by Application (2016-2021)
8.3.2 China 242 Sales Breakdown by Application (2022-2027)

9 Japan Human Prothrombin Complex Market Facts & Figures
9.1 Japan Human Prothrombin Complex Sales by Company
9.1.1 Japan Human Prothrombin Complex Sales by Company (2016-2021)
9.1.2 Japan Human Prothrombin Complex Revenue by Company (2016-2021)
9.2 Japan Human Prothrombin Complex Sales Breakdown by Type
9.2.1 Japan Human Prothrombin Complex Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Prothrombin Complex Sales Breakdown by Type (2022-2027)
9.3 Japan Human Prothrombin Complex Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Human Prothrombin Complex Market Facts & Figures
10.1 Southeast Asia Human Prothrombin Complex Sales by Company
10.1.1 Southeast Asia Human Prothrombin Complex Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Prothrombin Complex Revenue by Company (2016-2021)
10.2 Southeast Asia Human Prothrombin Complex Sales Breakdown by Type
10.2.1 Southeast Asia Human Prothrombin Complex Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Prothrombin Complex Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Prothrombin Complex Sales Breakdown by Application
10.3.1 Southeast Asia MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia MT Sales Breakdown by Application (2022-2027)

11 India Human Prothrombin Complex Market Facts & Figures
11.1 India Human Prothrombin Complex Sales by Company
11.1.1 India Human Prothrombin Complex Sales by Company (2016-2021)
11.1.2 India Human Prothrombin Complex Revenue by Company (2016-2021)
11.2 India Human Prothrombin Complex Sales Breakdown by Type
11.2.1 India Human Prothrombin Complex Sales Breakdown by Type (2016-2021)
11.2.2 India Human Prothrombin Complex Sales Breakdown by Type (2022-2027)
11.3 India Human Prothrombin Complex Sales Breakdown by Application
11.3.1 India Human Prothrombin Complex Sales Breakdown by Application (2016-2021)
11.3.2 India Human Prothrombin Complex Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Human Prothrombin Complex Business
12.1 Takeda
12.1.1 Takeda Corporation Information
12.1.2 Takeda Business Overview
12.1.3 Takeda Human Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Takeda Human Prothrombin Complex Products Offered
12.1.5 Takeda Recent Development
12.2 CSL
12.2.1 CSL Corporation Information
12.2.2 CSL Business Overview
12.2.3 CSL Human Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
12.2.4 CSL Human Prothrombin Complex Products Offered
12.2.5 CSL Recent Development
12.3 Grifols
12.3.1 Grifols Corporation Information
12.3.2 Grifols Business Overview
12.3.3 Grifols Human Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Grifols Human Prothrombin Complex Products Offered
12.3.5 Grifols Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Business Overview
12.4.3 Octapharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Octapharma Human Prothrombin Complex Products Offered
12.4.5 Octapharma Recent Development
12.5 Hualan Biological
12.5.1 Hualan Biological Corporation Information
12.5.2 Hualan Biological Business Overview
12.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Hualan Biological Human Prothrombin Complex Products Offered
12.5.5 Hualan Biological Recent Development
12.6 Meheco Xinxing Pharma
12.6.1 Meheco Xinxing Pharma Corporation Information
12.6.2 Meheco Xinxing Pharma Business Overview
12.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Products Offered
12.6.5 Meheco Xinxing Pharma Recent Development

13 Human Prothrombin Complex Manufacturing Cost Analysis
13.1 Human Prothrombin Complex Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Prothrombin Complex
13.4 Human Prothrombin Complex Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Prothrombin Complex Distributors List
14.3 Human Prothrombin Complex Customers

15 Market Dynamics
15.1 Human Prothrombin Complex Market Trends
15.2 Human Prothrombin Complex Drivers
15.3 Human Prothrombin Complex Market Challenges
15.4 Human Prothrombin Complex Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Human Prothrombin Complex Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Human Prothrombin Complex Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Human Prothrombin Complex Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Human Prothrombin Complex Sales (MT) by Region (2016-2021)
Table 5. Global Human Prothrombin Complex Sales Market Share by Region (2016-2021)
Table 6. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Human Prothrombin Complex Revenue Share by Region (2016-2021)
Table 8. Global Human Prothrombin Complex Sales (MT) Forecast by Region (2022-2027)
Table 9. Global Human Prothrombin Complex Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Human Prothrombin Complex Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Human Prothrombin Complex Revenue Share Forecast by Region (2022-2027)
Table 12. Global Human Prothrombin Complex Sales (MT) of Key Companies (2016-2021)
Table 13. Global Human Prothrombin Complex Sales Share by Company (2016-2021)
Table 14. Global Human Prothrombin Complex Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Human Prothrombin Complex Revenue Share by Company (2016-2021)
Table 16. Global Human Prothrombin Complex by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Prothrombin Complex as of 2020)
Table 17. Global Human Prothrombin Complex Average Price (K USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Human Prothrombin Complex Manufacturing Sites and Area Served
Table 19. Manufacturers Human Prothrombin Complex Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Human Prothrombin Complex Sales (MT) by Type (2016-2021)
Table 22. Global Human Prothrombin Complex Sales Share by Type (2016-2021)
Table 23. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Human Prothrombin Complex Price (K USD/MT) by Type (2016-2021)
Table 25. Global Human Prothrombin Complex Sales Share by Type (2022-2027)
Table 26. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Human Prothrombin Complex Revenue Share by Type (2022-2027)
Table 28. Global Human Prothrombin Complex Price (K USD/MT) by Type (2022-2027)
Table 29. Global Human Prothrombin Complex Sales (MT) by Application (2016-2021)
Table 30. Global Human Prothrombin Complex Sales Share by Application (2016-2021)
Table 31. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Human Prothrombin Complex Price (K USD/MT) by Application (2016-2021)
Table 33. Global Human Prothrombin Complex Sales (MT) by Application (2022-2027)
Table 34. Global Human Prothrombin Complex Sales Share by Application (2022-2027)
Table 35. Global Human Prothrombin Complex Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Human Prothrombin Complex Revenue Share by Application (2022-2027)
Table 37. Global Human Prothrombin Complex Price (K USD/MT) by Application (2022-2027)
Table 38. North America Human Prothrombin Complex Sales (MT) by Company (2016-2021)
Table 39. North America Human Prothrombin Complex Sales Market Share by Company (2016-2021)
Table 40. North America Human Prothrombin Complex Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Human Prothrombin Complex Revenue Market Share by Company (2016-2021)
Table 42. North America Human Prothrombin Complex Sales by Type (2016-2021) & (MT)
Table 43. North America Human Prothrombin Complex Sales Market Share by Type (2016-2021)
Table 44. North America Human Prothrombin Complex Sales by Type (2022-2027) & (MT)
Table 45. North America Human Prothrombin Complex Sales Market Share by Type (2022-2027)
Table 46. North America Human Prothrombin Complex Sales by Application (2016-2021) & (MT)
Table 47. North America Human Prothrombin Complex Sales Market Share by Application (2016-2021)
Table 48. North America Human Prothrombin Complex Sales by Application (2022-2027) & (MT)
Table 49. North America Human Prothrombin Complex Sales Market Share by Application (2022-2027)
Table 50. Europe Human Prothrombin Complex Sales (MT) by Company (2016-2021)
Table 51. Europe Human Prothrombin Complex Sales Market Share by Company (2016-2021)
Table 52. Europe Human Prothrombin Complex Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Human Prothrombin Complex Revenue Market Share by Company (2016-2021)
Table 54. Europe Human Prothrombin Complex Sales by Type (2016-2021) & (MT)
Table 55. Europe Human Prothrombin Complex Sales Market Share by Type (2016-2021)
Table 56. Europe Human Prothrombin Complex Sales by Type (2022-2027) & (MT)
Table 57. Europe Human Prothrombin Complex Sales Market Share by Type (2022-2027)
Table 58. Europe Human Prothrombin Complex Sales by Application (2016-2021) & (MT)
Table 59. Europe Human Prothrombin Complex Sales Market Share by Application (2016-2021)
Table 60. Europe Human Prothrombin Complex Sales by Application (2022-2027) & (MT)
Table 61. Europe Human Prothrombin Complex Sales Market Share by Application (2022-2027)
Table 62. China Human Prothrombin Complex Sales (MT) by Company (2016-2021)
Table 63. China Human Prothrombin Complex Sales Market Share by Company (2016-2021)
Table 64. China Human Prothrombin Complex Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Human Prothrombin Complex Revenue Market Share by Company (2016-2021)
Table 66. China Human Prothrombin Complex Sales by Type (2016-2021) & (MT)
Table 67. China Human Prothrombin Complex Sales Market Share by Type (2016-2021)
Table 68. China Human Prothrombin Complex Sales by Type (2022-2027) & (MT)
Table 69. China Human Prothrombin Complex Sales Market Share by Type (2022-2027)
Table 70. China Human Prothrombin Complex Sales by Application (2016-2021) & (MT)
Table 71. China Human Prothrombin Complex Sales Market Share by Application (2016-2021)
Table 72. China Human Prothrombin Complex Sales by Application (2022-2027) & (MT)
Table 73. China Human Prothrombin Complex Sales Market Share by Application (2022-2027)
Table 74. Japan Human Prothrombin Complex Sales (MT) by Company (2016-2021)
Table 75. Japan Human Prothrombin Complex Sales Market Share by Company (2016-2021)
Table 76. Japan Human Prothrombin Complex Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Human Prothrombin Complex Revenue Market Share by Company (2016-2021)
Table 78. Japan Human Prothrombin Complex Sales by Type (2016-2021) & (MT)
Table 79. Japan Human Prothrombin Complex Sales Market Share by Type (2016-2021)
Table 80. Japan Human Prothrombin Complex Sales by Type (2022-2027) & (MT)
Table 81. Japan Human Prothrombin Complex Sales Market Share by Type (2022-2027)
Table 82. Japan Human Prothrombin Complex Sales by Application (2016-2021) & (MT)
Table 83. Japan Human Prothrombin Complex Sales Market Share by Application (2016-2021)
Table 84. Japan Human Prothrombin Complex Sales by Application (2022-2027) & (MT)
Table 85. Japan Human Prothrombin Complex Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Human Prothrombin Complex Sales (MT) by Company (2016-2021)
Table 87. Southeast Asia Human Prothrombin Complex Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Human Prothrombin Complex Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Human Prothrombin Complex Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Human Prothrombin Complex Sales by Type (2016-2021) & (MT)
Table 91. Southeast Asia Human Prothrombin Complex Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Human Prothrombin Complex Sales by Type (2022-2027) & (MT)
Table 93. Southeast Asia Human Prothrombin Complex Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Human Prothrombin Complex Sales by Application (2016-2021) & (MT)
Table 95. Southeast Asia Human Prothrombin Complex Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Human Prothrombin Complex Sales by Application (2022-2027) & (MT)
Table 97. Southeast Asia Human Prothrombin Complex Sales Market Share by Application (2022-2027)
Table 98. India Human Prothrombin Complex Sales (MT) by Company (2016-2021)
Table 99. India Human Prothrombin Complex Sales Market Share by Company (2016-2021)
Table 100. India Human Prothrombin Complex Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Human Prothrombin Complex Revenue Market Share by Company (2016-2021)
Table 102. India Human Prothrombin Complex Sales by Type (2016-2021) & (MT)
Table 103. India Human Prothrombin Complex Sales Market Share by Type (2016-2021)
Table 104. India Human Prothrombin Complex Sales by Type (2022-2027) & (MT)
Table 105. India Human Prothrombin Complex Sales Market Share by Type (2022-2027)
Table 106. India Human Prothrombin Complex Sales by Application (2016-2021) & (MT)
Table 107. India Human Prothrombin Complex Sales Market Share by Application (2016-2021)
Table 108. India Human Prothrombin Complex Sales by Application (2022-2027) & (MT)
Table 109. India Human Prothrombin Complex Sales Market Share by Application (2022-2027)
Table 110. Takeda Corporation Information
Table 111. Takeda Description and Business Overview
Table 112. Takeda Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2016-2021)
Table 113. Takeda Human Prothrombin Complex Product
Table 114. Takeda Recent Development
Table 115. CSL Corporation Information
Table 116. CSL Description and Business Overview
Table 117. CSL Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2016-2021)
Table 118. CSL Human Prothrombin Complex Product
Table 119. CSL Recent Development
Table 120. Grifols Corporation Information
Table 121. Grifols Description and Business Overview
Table 122. Grifols Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2016-2021)
Table 123. Grifols Human Prothrombin Complex Product
Table 124. Grifols Recent Development
Table 125. Octapharma Corporation Information
Table 126. Octapharma Description and Business Overview
Table 127. Octapharma Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2016-2021)
Table 128. Octapharma Human Prothrombin Complex Product
Table 129. Octapharma Recent Development
Table 130. Hualan Biological Corporation Information
Table 131. Hualan Biological Description and Business Overview
Table 132. Hualan Biological Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2016-2021)
Table 133. Hualan Biological Human Prothrombin Complex Product
Table 134. Hualan Biological Recent Development
Table 135. Meheco Xinxing Pharma Corporation Information
Table 136. Meheco Xinxing Pharma Description and Business Overview
Table 137. Meheco Xinxing Pharma Human Prothrombin Complex Sales (MT), Revenue (Million USD), Price (K USD/MT) and Gross Margin (2016-2021)
Table 138. Meheco Xinxing Pharma Human Prothrombin Complex Product
Table 139. Meheco Xinxing Pharma Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Human Prothrombin Complex Distributors List
Table 143. Human Prothrombin Complex Customers List
Table 144. Human Prothrombin Complex Market Trends
Table 145. Human Prothrombin Complex Market Drivers
Table 146. Human Prothrombin Complex Market Challenges
Table 147. Human Prothrombin Complex Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Prothrombin Complex Product Picture
Figure 2. Global Human Prothrombin Complex Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Prothrombin Complex Sales Market Share by Application in 2021 & 2027
Figure 6. Hemophilia B Examples
Figure 7. Vitamin K Deficiency Examples
Figure 8. Others Examples
Figure 9. Global Human Prothrombin Complex Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Human Prothrombin Complex Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Human Prothrombin Complex Sales (MT) Growth Rate (2016-2027)
Figure 12. Global Human Prothrombin Complex Price Trends Growth Rate (2016-2027) (K USD/MT)
Figure 13. Global Human Prothrombin Complex Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Human Prothrombin Complex Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Human Prothrombin Complex Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Human Prothrombin Complex Sales (MT) Growth Rate (2016-2027)
Figure 17. Europe Human Prothrombin Complex Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Human Prothrombin Complex Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Human Prothrombin Complex Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Human Prothrombin Complex Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Human Prothrombin Complex Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Human Prothrombin Complex Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Human Prothrombin Complex Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Human Prothrombin Complex Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Human Prothrombin Complex Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Human Prothrombin Complex Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Human Prothrombin Complex Players Market Share by Revenue in Human Prothrombin Complex: 2016 & 2020
Figure 28. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Human Prothrombin Complex Revenue Share by Type (2016-2021)
Figure 30. Global Human Prothrombin Complex Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Human Prothrombin Complex Revenue Share by Application (2016-2021)
Figure 32. Global Human Prothrombin Complex Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Human Prothrombin Complex Sales Market Share by Type in 2020
Figure 34. North America Human Prothrombin Complex Sales Market Share by Application in 2020
Figure 35. Europe Human Prothrombin Complex Sales Market Share by Type in 2020
Figure 36. Europe Human Prothrombin Complex Sales Market Share by Application in 2020
Figure 37. China Human Prothrombin Complex Sales Market Share by Type in 2020
Figure 38. China Human Prothrombin Complex Sales Market Share by Application in 2020
Figure 39. Japan Human Prothrombin Complex Sales Market Share by Type in 2020
Figure 40. Japan Human Prothrombin Complex Sales Market Share by Application in 2020
Figure 41. Southeast Asia Human Prothrombin Complex Sales Market Share by Type in 2020
Figure 42. Southeast Asia Human Prothrombin Complex Sales Market Share by Application in 2020
Figure 43. India Human Prothrombin Complex Sales Market Share by Type in 2020
Figure 44. India Human Prothrombin Complex Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Human Prothrombin Complex
Figure 47. Manufacturing Process Analysis of Human Prothrombin Complex
Figure 48. Human Prothrombin Complex Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed